Saudi Arabia Advances Medical Device Regulation: A Focus on Classification and Compliance

Saudi Arabia continues to enhance its regulatory framework for medical devices, with recent updates reinforcing the importance of accurate product classification and compliance.

In early 2026, the Saudi Food and Drug Authority introduced updated product classification guidance, providing clearer requirements for how products are categorised and regulated within the Kingdom.

This development reflects Saudi Arabia’s broader ambition to establish a more structured, transparent, and internationally aligned regulatory system.

Strengthening Product Classification Requirements

One of the key updates focuses on how products are classified before entering the market.

Under the revised guidance:

• Companies must obtain formal classification decisions through the e-GHAD platform.

• Classification approvals are valid for one year.

• Submissions must include detailed information on:

*Intended use

*Mechanism of action

*Product claims

These elements are critical in determining whether a product is regulated as a medical device, drug, or another category.

Increased Scrutiny on Product Claims

The updated guidance also introduces stricter oversight on how products are positioned in the market.

For example:

• Products making therapeutic or medicinal claims may be reclassified into higher regulatory categories.

• Ingredients exceeding certain thresholds may trigger reclassification as drugs.

• Cosmetic and general-use products must strictly avoid medical claims.

This reinforces the need for manufacturers to carefully align product design, labelling, and marketing claims with regulatory expectations.

Alignment with Digital Regulatory Systems

Another important aspect of the update is the integration of classification processes into the e-GHAD digital platform.

This reflects Saudi Arabia’s ongoing efforts to:

• Centralize regulatory submissions

• Improve transparency and traceability.

• Streamline communication between regulators and manufacturers.

Digitalisation is becoming a key component of regulatory compliance in the region.

Part of a Broader Regulatory Evolution

These classification updates are part of a wider regulatory transformation led by the Saudi Food and Drug Authority.

Recent developments also include:

• Strengthened quality management and inspection requirements for medical devices

• Increased focus on technical and clinical documentation

• Reinforced expectations for post-market compliance and lifecycle management

Together, these changes signal a move toward a more comprehensive and enforcement-driven regulatory framework.

What This Means for Medical Device Manufacturers

For companies entering or operating in Saudi Arabia, these updates carry important implications.

1. Classification Becomes a Critical First Step

Incorrect classification can lead to delays, rejection, or reclassification into stricter regulatory pathways.

2. Higher Compliance Expectations

Manufacturers must ensure that documentation, claims, and product design are fully aligned with SFDA requirements.

3. Increased Regulatory Predictability

Clearer guidance helps reduce ambiguity, allowing companies to plan more effectively for market entry.

Saudi Arabia’s Direction: Precision and Control

Saudi Arabia is positioning itself as a highly regulated and strategically important healthcare market in the Middle East.

By strengthening classification systems and compliance requirements, the regulator is:

• Enhancing patient safety

• Improving regulatory efficiency

• Aligning with international best practices

For manufacturers, success in Saudi Arabia will depend on precision, preparation, and a strong regulatory strategy.

How ARQon Can Support

At ARQon International Group, we support medical device companies navigating evolving regulatory environments across Asia and the Middle East.

Our expertise includes:

• Product classification and regulatory strategy

• Medical device registration and compliance

• Regulatory intelligence and monitoring

• Market entry and expansion planning

As regulatory frameworks become more structured and demanding, having the right partner ensures efficient and compliant market access.